Screener
Krystal Biotech, Inc. KRYS Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s net debt?
- Krystal Biotech, Inc. (KRYS) reported net debt of -$492.2M in Q1 2026.
- How has Krystal Biotech, Inc.'s net debt changed year-over-year?
- Krystal Biotech, Inc.'s net debt decreased by 64.6% year-over-year, from -$299.11M to -$492.2M.
- What is the long-term trend for Krystal Biotech, Inc.'s net debt?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s net debt has grown at a 13.0% compound annual growth rate (CAGR), from -$264.32M to -$486.97M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Krystal Biotech, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude